TECH Bio-Techne Corp

  1. Stocks
  2. Healthcare
  3. NASDAQ: TECH

Price (delayed)

$72.12

Market cap

$11.31B

P/E Ratio

61.64

Dividend/share

$0.32

EPS

$1.17

Enterprise value

$11.33B

?
Relative Growth: Rel. Growth: 68
Relative Strength: Rel. Strength: 84
Relative Valuation: Rel. Valuation: 34
Relative Profitability: Rel. Profitability: 90

Contact: David Clair, Senior Director, Corporate Development [email protected] 612-656-4416 SOURCE Bio-Techne Corporation Related Links https://www.bio-techne.com/

Highlights
TECH's EPS has surged by 149% year-on-year and by 65% since the previous quarter
The net income has soared by 148% YoY and by 66% from the previous quarter
Sector: Healthcare
Industry: Biotechnology
Website: http://www.bio-techne.com
Peers: TMO DHR QGEN BDX

Key stats

What are the main financial stats of TECH

TECH stock price

How has the Bio-Techne stock price performed over time
Intraday
0.06%
1 week
-0.43%
1 month
-0.04%
1 year
35.54%
YTD
22.63%
QTD
2.08%

Financial performance

How have Bio-Techne's revenue and profit performed over time
Revenue
$1.22B
Gross profit
$799.07M
Operating income
$251.89M
Net income
$181.86M
Gross margin
65.8%
Net margin
15%
Bio-Techne's net margin has surged by 150% YoY and by 67% QoQ
The net income has soared by 148% YoY and by 66% from the previous quarter
The company's operating income has surged by 146% YoY and by 64% QoQ
Bio-Techne's operating margin has surged by 146% YoY and by 63% QoQ

Price vs fundamentals

How does TECH's price correlate with its fundamentals

Growth

What is Bio-Techne's growth rate over time

Valuation

What is Bio-Techne stock price valuation
TECH P/E details
P/E
61.64
P/B
5.36
P/S
9.26
EV/EBIT
45.28
EV/EBITDA
32.6
EV/Sales
9.33
TECH's EPS has surged by 149% year-on-year and by 65% since the previous quarter
TECH's P/E is 31% below its last 4 quarters average of 89.6 and 13% below its 5-year quarterly average of 70.9
The stock's price to book (P/B) is 19% more than its last 4 quarters average of 4.5 but 16% less than its 5-year quarterly average of 6.4
Bio-Techne's equity has increased by 10% YoY
The price to sales (P/S) is 22% higher than the last 4 quarters average of 7.6 but 13% lower than the 5-year quarterly average of 10.7

Efficiency

How efficient is Bio-Techne business performance
TECH's return on assets has surged by 154% year-on-year and by 65% since the previous quarter
Bio-Techne's ROIC has soared by 152% YoY and by 66% from the previous quarter
Bio-Techne's return on equity has surged by 147% YoY and by 62% QoQ
TECH's return on sales has surged by 134% year-on-year and by 60% since the previous quarter

Dividends

What is TECH's dividend history
Dividend details
DPS
$0.32
Dividend yield
0.44%
Payout ratio
27.4%
Recent dividends

Special dividends are included in TTM DPS and yield

Financial health

How did Bio-Techne financials performed over time
The quick ratio has increased by 40% year-on-year and by 6% since the previous quarter
TECH's current ratio is up by 32% YoY
Bio-Techne's debt is 86% lower than its equity
TECH's debt to equity is down by 39% year-on-year
Bio-Techne's debt has decreased by 35% YoY

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.